In addition to the kidneys and liver, the innovative NanOx system also works well in heart perfusion, as proven by a recent study conducted in collaboration with the Dr. n. med. Piotr Kolsut , Head of the Department of Cardiothoracic Surgery and Transplantation at the National Institute of Cardiology named after him. Stefan Cardinal Wyszynski.
The Polish company NanoGroup, or more precisely its subsidiary NanoSanguis, has successfully performed a 4-hour heart perfusion using the NanOx system under development. The organ was harvested in a DBD model and perfused under normothermic conditions with NanOx fluid after attachment.
Thanks to the clever design of the device, it was possible to defibrillate with cardiac spoons during perfusion without damaging the components of the apparatus, and to read the ECG.
Analysis of perfusion parameters and tissue damage markers showed a reconditioning effect of the NanOx system on the organ lasting for 2 hours, while an increase in vascular flow resistance was observed during the following two hours.
Throughout the perfusion process, oxygen consumption remains at a constant, satisfactorily high level.
The need to achieve better perfusion parameters and biochemical analysis results, as well as the positive evaluation of the NanOx system by a prominent specialist, dr. n. med. Piotr Kolsut motivate the company to continue working and improving the device and the fluid.